Swayampakula Ramakanth Analyst Performance

Managing Directo at HC Wainwright

Swayampakula Ramakanth is a stock analyst at HC Wainwright focused in the medical sector, covering 78 publicly traded companies. Over the past year, Swayampakula Ramakanth has issued 108 stock ratings, including strong buy, buy, and hold recommendations. While full access to Swayampakula Ramakanth's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Swayampakula Ramakanth's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
460 Last 11 Years
Buy Recommendations
94.54% 433 Buy Ratings
Companies Covered
78 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.7%3 ratings
Buy93.9%430 ratings
Hold5.5%25 ratings
Sell0.0%0 ratings

Out of 458 total stock ratings issued by Swayampakula Ramakanth at HC Wainwright, the majority (93.9%) have been Buy recommendations, followed by 5.5% Hold and 0.7% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
89.7% of companies on NASDAQ
70 companies
NYSEAMERICAN
3.8% of companies on NYSEAMERICAN
3 companies
NYSE
2.6% of companies on NYSE
2 companies
OTCMKTS
2.6% of companies on OTCMKTS
2 companies
TSE
1.3% of companies on TSE
1 company

Swayampakula Ramakanth, an analyst at HC Wainwright, currently covers 78 companies listed on NASDAQ, NYSEAMERICAN, NYSE, OTCMKTS and TSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
72 companies
92.3%
Manufacturing
4 companies
5.1%
Computer and Technology
2 companies
2.6%

Swayampakula Ramakanth of HC Wainwright specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and Computer and Technology companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
35 companies
44.9%
PHARMACEUTICAL PREPARATIONS
10 companies
12.8%
MED - DRUGS
9 companies
11.5%
MED INSTRUMENTS
6 companies
7.7%
MEDICAL INFO SYS
3 companies
3.8%
SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES
2 companies
2.6%
BIOTECHNOLOGY
2 companies
2.6%
MED PRODUCTS
2 companies
2.6%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
1 company
1.3%
INTERNET SOFTWARE
1 company
1.3%
MED - GENERIC DRG
1 company
1.3%
MED - HMO
1 company
1.3%
ELEC COMP - SEMIC
1 company
1.3%
LABORATORY APPARATUS & FURNITURE
1 company
1.3%
SURGICAL APPLIANCES & SUPPLIES
1 company
1.3%
LARGE CAP PHARMA
1 company
1.3%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC
1 company
1.3%

About Swayampakula Ramakanth

Dr. Ramakanth is a Managing Director of Equity Research at H.C. Wainwright whose research focuses on the healthcare sector. Dr. Ramakanth’s research covers companies operating in oncology, wound health, medical devices, spine health and animal health. Dr. Ramakanth possesses over ten years of experience as a Life Sciences Equity Analyst as well as seven years of biotechnology industry experience. Prior to joining H.C. Wainwright, Dr. Ramakanth worked as a Junior Analyst at both Jefferies and Merrill Lynch covering large cap pharmaceuticals. Dr. Ramakanth was also a Junior Analyst at both First Albany and Rodman & Renshaw where he focused on biotechnology companies. Dr. Ramakanth also conducted bench research and directed a preclinical drug development group at Regeneron Pharmaceuticals, Inc. Dr. Ramakanth presented at various regional and international conferences and published in several peer-reviewed journals. Dr. Ramakanth’s educational background includes a Ph.D. in Pharmacology/Toxicology from the University of Utah, an MBA from Rutgers University, an M.S. in Pharmaceutics from Auburn University, and a B. Pharm (Hons.) from BITS, India. Dr. Ramakanth also held a post-doctoral fellowship at the University of Texas MD Anderson Cancer Center.
Follow on LinkedIn

Swayampakula Ramakanth's Ratings History at HC Wainwright

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
6/22/2026Initiated Coverage$13.28$20.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
6/15/2026Reiterated Rating$99.35Buy
Humacyte, Inc. stock logo
HUMA
Humacyte
6/11/2026Boost Price Target$1.04$4.00Buy
Actuate Therapeutics, Inc. stock logo
ACTU
Actuate Therapeutics
6/10/2026Reiterated Rating$2.01Buy
Nuvalent, Inc. stock logo
NUVL
Nuvalent
6/9/2026Downgrade$122.82$124.00Neutral
IN8bio, Inc. stock logo
INAB
IN8bio
6/4/2026Reiterated Rating$1.54Buy
Celcuity, Inc. stock logo
CELC
Celcuity
6/3/2026Lower Price Target$91.42$145.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
6/2/2026Boost Price Target$70.44$95.00Buy
MediWound Ltd. stock logo
MDWD
MediWound
5/28/2026Reiterated Rating$14.33$36.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
5/28/2026Boost Price Target$66.65$95.00Buy
Precigen, Inc. stock logo
PGEN
Precigen
5/28/2026Boost Price Target$4.40$14.00Buy
Humacyte, Inc. stock logo
HUMA
Humacyte
5/26/2026Reiterated Rating$1.09$3.00Buy
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
5/19/2026Reiterated Rating$1.24$5.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
5/18/2026Boost Price Target$137.68$185.00Buy
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
5/18/2026Reiterated Rating$0.55$4.00Buy
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
5/18/2026Reiterated Rating$14.31$31.00Buy
Actuate Therapeutics, Inc. stock logo
ACTU
Actuate Therapeutics
5/18/2026Reiterated Rating$2.43$15.00Buy
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
5/15/2026Boost Price Target$29.40$57.00Buy
Precigen, Inc. stock logo
PGEN
Precigen
5/14/2026Boost Price Target$4.15$11.00Buy
Can-Fite BioPharma Ltd. stock logo
CANF
Can-Fite BioPharma
5/12/2026Set Price Target$3.36$5.00Buy
Vericel Corporation stock logo
VCEL
Vericel
5/8/2026Reiterated Rating$35.13$64.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
5/7/2026Set Price Target$101.07$185.00
BioStem Technologies, Inc. stock logo
BSEM
BioStem Technologies
5/6/2026Upgrade$4.18Strong-Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
5/4/2026Boost Price Target$51.42$75.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
5/4/2026Boost Price Target$108.37$175.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
4/27/2026Boost Price Target$93.03$150.00Buy
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
4/24/2026Reiterated Rating$4.25$16.00Buy
Actuate Therapeutics, Inc. stock logo
ACTU
Actuate Therapeutics
4/22/2026Reiterated Rating$2.27$15.00Buy
Nuvalent, Inc. stock logo
NUVL
Nuvalent
4/21/2026Reiterated Rating$108.24$155.00Buy
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
4/15/2026Lower Price Target$15.87$31.00Buy
Actuate Therapeutics, Inc. stock logo
ACTU
Actuate Therapeutics
4/13/2026Lower Price Target$1.72$15.00Buy
FOCL
FocalTherics
4/9/2026Lower Price Target$3.32$10.00Buy
RenovoRx, Inc. stock logo
RNXT
RenovoRx
4/8/2026Reiterated Rating$0.94$3.00Buy
Innate Pharma S.A. Sponsored ADR stock logo
IPHA
Innate Pharma
4/7/2026Reiterated Rating$1.35$5.00Buy
Precigen, Inc. stock logo
PGEN
Precigen
3/26/2026Boost Price Target$3.10$10.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
3/25/2026Boost Price Target$1.92$10.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
3/25/2026Lower Price Target$40.78$60.00Buy
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
3/24/2026Reiterated Rating$1.42$7.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
3/23/2026Reiterated Rating$88.51$130.00Buy
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
3/20/2026Boost Price Target$22.67$52.00Buy
Bill Gates said this would never work. Then he wrote a $100M check. (Ad)

Bill Gates spent a decade insisting this energy source couldn't supply more than 5% of global power. Then he toured a construction site in the Nevada desert and told Bloomberg he now believes it could reach 20%. He followed that reversal with a $100 million investment. Facebook's co-founder added $462 million. Tesla's co-founder and Norway's sovereign wealth fund also took positions. One company - 60 years of operating history, revenue approaching $1 billion - sits at the center of all of it, with a July 4th catalyst that locks in its competitive advantage for eight years.tc pixel

See the stock behind the 100 million dollar reversal right here
Lifeward Ltd. stock logo
LFWD
Lifeward
3/19/2026Boost Price Target$6.72$10.00Buy
IN8bio, Inc. stock logo
INAB
IN8bio
3/13/2026Reiterated Rating$1.91Buy
ALX Oncology Holdings Inc. stock logo
ALXO
ALX Oncology
3/10/2026Reiterated Rating$2.13$4.00Buy
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
3/9/2026Reiterated Rating$3.22$16.00Buy
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
3/9/2026Boost Price Target$77.56$130.00Buy
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
3/2/2026Boost Price Target$16.99$37.00Buy
Vericel Corporation stock logo
VCEL
Vericel
2/27/2026Boost Price Target$36.13$64.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
2/20/2026Lower Price Target$34.24$67.00Buy
Verastem, Inc. stock logo
VSTM
Verastem
2/4/2026Initiated Coverage$6.30$18.00Buy
electroCore, Inc. stock logo
ECOR
electroCore
1/26/2026Lower Price Target$7.47$18.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
1/26/2026Boost Price Target$94.29$130.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
1/22/2026Boost Price Target$41.47$105.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
1/13/2026Reiterated Rating$89.50$102.00Buy
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
1/9/2026Reiterated Rating$10.45$30.00Buy
Compugen Ltd. stock logo
CGEN
Compugen
1/7/2026Initiated Coverage$1.55$4.00Buy
Compugen Ltd. stock logo
CGEN
Compugen
1/7/2026Initiated Coverage$1.72$4.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
1/2/2026Lower Price Target$34.80$90.00Buy
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
12/31/2025Downgrade$10.61Neutral
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
12/19/2025Boost Price Target$1.73$7.00Buy
Absci Corporation stock logo
ABSI
Absci
12/17/2025Boost Price Target$3.54$8.00Buy
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
12/2/2025Lower Price Target$33.99$45.00Buy
Humacyte, Inc. stock logo
HUMA
Humacyte
12/1/2025Reiterated Rating$1.36$3.00Buy
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
11/25/2025Reiterated Rating$31.53$70.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
11/25/2025Reiterated Rating$77.71$145.00Buy
MediWound Ltd. stock logo
MDWD
MediWound
11/21/2025Reiterated Rating$16.86$36.00Buy
Actuate Therapeutics, Inc. stock logo
ACTU
Actuate Therapeutics
11/19/2025Reiterated Rating$6.10$20.00Buy
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
11/18/2025Set Price Target$4.18$6.00Buy
Lifeward Ltd. stock logo
LFWD
Lifeward
11/18/2025Lower Price Target$7.14$54.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
11/17/2025Reiterated Rating$92.68$94.00Neutral
Nuvalent, Inc. stock logo
NUVL
Nuvalent
11/17/2025Boost Price Target$112.06$155.00Buy
Precigen, Inc. stock logo
PGEN
Precigen
11/14/2025Boost Price Target$3.86$9.00Buy
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
11/14/2025Lower Price Target$9.75$32.00Buy
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
11/10/2025Boost Price Target$36.28$47.00Buy
Personalis, Inc. stock logo
PSNL
Personalis
11/6/2025Boost Price Target$7.66$10.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
11/5/2025Boost Price Target$70.97$81.00Buy
Can-Fite BioPharma Ltd. stock logo
CANF
Can-Fite BioPharma
11/4/2025Reiterated Rating$8.24$50.00Buy
Unicycive Therapeutics, Inc. stock logo
UNCY
Unicycive Therapeutics
10/29/2025Reiterated Rating$4.72$22.00Buy
Innate Pharma S.A. Sponsored ADR stock logo
IPHA
Innate Pharma
10/29/2025Set Price Target$2.10$5.00Buy
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
10/29/2025Boost Price Target$25.28$52.00Buy
Innate Pharma S.A. Sponsored ADR stock logo
IPHA
Innate Pharma
10/29/2025Upgrade$2.00Strong-Buy
Dyadic International Inc. stock logo
DYAI
Dyadic International
10/23/2025Initiated Coverage$1.10$3.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
10/22/2025Boost Price Target$65.50$77.00Buy
Verastem, Inc. stock logo
VSTM
Verastem
10/21/2025Reiterated Rating$8.02$14.00Buy
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
10/20/2025Set Price Target$11.42$30.00Buy
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
10/20/2025Reiterated Rating$6.79$16.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
10/20/2025Reiterated Rating$79.49$145.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
10/10/2025Reiterated Rating$88.36$145.00Buy
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
9/25/2025Boost Price Target$4.00$16.00Buy
Actuate Therapeutics, Inc. stock logo
ACTU
Actuate Therapeutics
9/23/2025Reiterated Rating$7.09$20.00Buy
Innate Pharma S.A. Sponsored ADR stock logo
IPHA
Innate Pharma
9/18/2025Downgrade$2.05Neutral
Four winners over 400%. Here's #5 (Ad)

CFA and CMT analyst Garrett Goggin called G2 Goldfields before it rose 1,023%, Reunion Gold before 538%, Highlander Silver before 741%, and Orogen Royalty before 416%. He also publicly predicted Newmont's 126% gain in 2025. Now Goggin says the 1974 petrodollar agreement between Washington and Riyadh has quietly expired, central banks are buying gold at the fastest pace since 1950, and a major monetary shift is underway. He has identified four specific positions - plus two bonus opportunities for readers.tc pixel

Read the full briefing and see all four positions plus two bonuses
Personalis, Inc. stock logo
PSNL
Personalis
9/8/2025Reiterated Rating$5.24$8.50Buy
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
9/8/2025Reiterated Rating$26.50$40.00Buy
CollPlant Biotechnologies Ltd. Sponsored ADR stock logo
CLGN
CollPlant Biotechnologies
8/21/2025Reiterated Rating$1.97$11.00Buy
Precigen, Inc. stock logo
PGEN
Precigen
8/19/2025Reiterated Rating$2.95$8.50Buy
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
8/19/2025Reiterated Rating$1.24$5.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
8/18/2025Boost Price Target$51.79$66.00Buy
Actuate Therapeutics, Inc. stock logo
ACTU
Actuate Therapeutics
8/18/2025Reiterated Rating$8.12$20.00Buy
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
8/14/2025Reiterated Rating$1.23Neutral
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
8/14/2025Reiterated Rating$40.40$60.00Buy
X4 Pharmaceuticals, Inc. stock logo
XFOR
X4 Pharmaceuticals
8/13/2025Set Price Target$2.58$3.50Buy
Precigen, Inc. stock logo
PGEN
Precigen
8/13/2025Reiterated Rating$1.80$6.00Buy
Humacyte, Inc. stock logo
HUMA
Humacyte
8/12/2025Lower Price Target$1.75$3.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
8/7/2025Boost Price Target$53.39$80.00Buy
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
8/7/2025Boost Price Target$10.64$31.00Buy
Personalis, Inc. stock logo
PSNL
Personalis
8/6/2025Lower Price Target$5.64$8.50Buy
Celcuity, Inc. stock logo
CELC
Celcuity
7/28/2025Boost Price Target$39.34$50.00Buy
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
7/7/2025Upgrade$1.27Neutral
Ocugen, Inc. stock logo
OCGN
Ocugen
6/24/2025Reiterated Rating$0.98$7.00Buy
Elevation Oncology, Inc. stock logo
ELEV
Elevation Oncology
6/10/2025Downgrade$0.38Neutral
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
5/29/2025Reiterated Rating$20.08$35.00Buy
Unicycive Therapeutics, Inc. stock logo
UNCY
Unicycive Therapeutics
5/27/2025Upgrade$5.53$90.00Strong-Buy
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
5/23/2025Reiterated Rating$16.15$29.00Buy
MediWound Ltd. stock logo
MDWD
MediWound
5/22/2025Set Price Target$19.89$31.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
5/19/2025Reiterated Rating$45.01$73.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
5/19/2025Reiterated Rating$10.61$27.00Buy
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
5/19/2025Reiterated Rating$1.21$5.00Buy
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
5/19/2025Reiterated Rating$1.41$5.50Buy
Affimed stock logo
AFMD
Affimed
5/14/2025Downgrade$0.11Neutral
iTeos Therapeutics, Inc. stock logo
ITOS
iTeos Therapeutics
5/14/2025Downgrade$7.98Neutral
Humacyte, Inc. stock logo
HUMA
Humacyte
5/14/2025Initiated Coverage$1.93$4.00Buy
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
5/13/2025Reiterated Rating$20.08$40.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
5/12/2025Lower Price Target$0.70$7.00Buy
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
5/9/2025Reiterated Rating$0.16Neutral
ALX Oncology Holdings Inc. stock logo
ALXO
ALX Oncology
5/9/2025Lower Price Target$0.46$2.00Buy
Personalis, Inc. stock logo
PSNL
Personalis
5/7/2025Boost Price Target$4.00$9.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
5/6/2025Lower Price Target$73.94$145.00Buy
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
5/6/2025Lower Price Target$7.15$60.00Buy
X4 Pharmaceuticals, Inc. stock logo
XFOR
X4 Pharmaceuticals
5/2/2025Boost Price Target$3.75$7.00Buy
Innate Pharma S.A. Sponsored ADR stock logo
IPHA
Innate Pharma
4/24/2025Reiterated Rating$2.00$11.00Buy
ImmunoPrecise Antibodies Ltd. stock logo
IPA
ImmunoPrecise Antibodies
4/11/2025Reiterated Rating$0.42$5.00Buy
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
4/2/2025Reiterated Rating$1.66$14.00Buy
Spectral AI, Inc. stock logo
MDAI
Spectral AI
4/2/2025Reiterated Rating$1.20$3.50Buy
Celcuity, Inc. stock logo
CELC
Celcuity
4/1/2025Reiterated Rating$10.11$27.00Buy
ImmunoPrecise Antibodies Ltd. stock logo
IPA
ImmunoPrecise Antibodies
3/31/2025Lower Price Target$0.39$5.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
3/31/2025Boost Price Target$100.43$150.00Buy
Innate Pharma S.A. Sponsored ADR stock logo
IPHA
Innate Pharma
3/28/2025Reiterated Rating$1.97$11.50Buy
FOCL
FocalTherics
3/28/2025Reiterated Rating$2.22$19.00Buy
RenovoRx, Inc. stock logo
RNXT
RenovoRx
3/27/2025Initiated Coverage$1.02$3.00Buy
X4 Pharmaceuticals, Inc. stock logo
XFOR
X4 Pharmaceuticals
3/27/2025Reiterated Rating$8.08$45.00Buy
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
3/21/2025Lower Price Target$17.04$260.00Buy
Quick favor to ask you (Ad)

Bill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $29.97 on his website. Inside, you'll find a 5-part trade framework designed to make every trade a safer one. This free offer won't last - the price goes back to $29.97 soon.tc pixel

Click here to claim your free copy before the offer ends
Elevation Oncology, Inc. stock logo
ELEV
Elevation Oncology
3/21/2025Lower Price Target$0.28$1.00Buy
MediWound Ltd. stock logo
MDWD
MediWound
3/20/2025Reiterated Rating$18.28$25.00Buy
Precigen, Inc. stock logo
PGEN
Precigen
3/20/2025Reiterated Rating$1.79$6.00Buy
Absci Corporation stock logo
ABSI
Absci
3/19/2025Reiterated Rating$3.08$7.00Buy
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
3/19/2025Reiterated Rating$1.06$5.00Buy
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
3/19/2025Reiterated Rating$14.68$33.00Buy
Spectral AI, Inc. stock logo
MDAI
Spectral AI
3/18/2025Reiterated Rating$1.76$3.50Buy
Actuate Therapeutics, Inc. stock logo
ACTU
Actuate Therapeutics
3/17/2025Initiated Coverage$7.25$20.00Buy
ImmunoPrecise Antibodies Ltd. stock logo
IPA
ImmunoPrecise Antibodies
3/14/2025Reiterated Rating$0.41$7.00Buy
IN8bio, Inc. stock logo
INAB
IN8bio
3/14/2025Lower Price Target$6.79$180.00Buy
electroCore, Inc. stock logo
ECOR
electroCore
3/13/2025Reiterated Rating$13.00$25.00Buy
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
3/12/2025Reiterated Rating$23.38$40.00Buy
Lifeward Ltd. stock logo
LFWD
Lifeward
3/11/2025Reiterated Rating$15.72$156.00Buy
Elevation Oncology, Inc. stock logo
ELEV
Elevation Oncology
3/10/2025Reiterated Rating$0.51$6.00Buy
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
3/7/2025Boost Price Target$13.22$24.00Buy
ALX Oncology Holdings Inc. stock logo
ALXO
ALX Oncology
3/7/2025Reiterated Rating$1.31$5.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
3/6/2025Reiterated Rating$0.57$8.00Buy
iTeos Therapeutics, Inc. stock logo
ITOS
iTeos Therapeutics
3/6/2025Reiterated Rating$7.26$46.00Buy
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
3/4/2025Reiterated Rating$7.23$135.00Buy
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
3/3/2025Reiterated Rating$32.89$70.00Buy
Personalis, Inc. stock logo
PSNL
Personalis
2/28/2025Reiterated Rating$4.24$8.00Buy
Vericel Corporation stock logo
VCEL
Vericel
2/28/2025Reiterated Rating$49.62$60.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
2/27/2025Reiterated Rating$63.37$115.00Buy
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
2/26/2025Reiterated Rating$11.10$33.00Buy
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
2/20/2025Reiterated Rating$2.55$14.00Buy
Lifeward Ltd. stock logo
LFWD
Lifeward
2/20/2025Reiterated Rating$22.08$156.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
2/13/2025Boost Price Target$0.66$8.00Buy
IN8bio, Inc. stock logo
INAB
IN8bio
2/12/2025Reiterated Rating$9.20$240.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
2/7/2025Reiterated Rating$68.04$80.00Buy
X4 Pharmaceuticals, Inc. stock logo
XFOR
X4 Pharmaceuticals
2/7/2025Reiterated Rating$16.50$45.00Buy
Innate Pharma S.A. Sponsored ADR stock logo
IPHA
Innate Pharma
2/6/2025Reiterated Rating$1.95$11.50Buy
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
2/3/2025Reiterated Rating$2.45$14.00Buy
Cypherpunk Technologies stock logo
CYPH
Cypherpunk Technologies
1/29/2025Downgrade$0.65Neutral
Personalis, Inc. stock logo
PSNL
Personalis
1/27/2025Lower Price Target$6.12$8.00Buy
ALX Oncology Holdings Inc. stock logo
ALXO
ALX Oncology
1/24/2025Lower Price Target$1.63$5.00Buy
Precigen, Inc. stock logo
PGEN
Precigen
1/23/2025Reiterated Rating$1.13$6.00Buy
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
1/23/2025Boost Price Target$15.77$33.00Buy
Innate Pharma S.A. Sponsored ADR stock logo
IPHA
Innate Pharma
1/17/2025Reiterated Rating$1.67$11.50Buy
Absci Corporation stock logo
ABSI
Absci
1/17/2025Reiterated Rating$2.80$7.00Buy
Cypherpunk Technologies stock logo
CYPH
Cypherpunk Technologies
1/16/2025Reiterated Rating$3.25$5.50Buy
iTeos Therapeutics, Inc. stock logo
ITOS
iTeos Therapeutics
1/16/2025Reiterated Rating$7.77$21.00Buy
Vericel Corporation stock logo
VCEL
Vericel
1/15/2025Reiterated Rating$58.67$60.00Buy
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
1/14/2025Reiterated Rating$1.93$5.50Buy
Elevation Oncology, Inc. stock logo
ELEV
Elevation Oncology
1/14/2025Reiterated Rating$0.72$6.00Buy
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
1/14/2025Reiterated Rating$10.68$135.00Buy
X4 Pharmaceuticals, Inc. stock logo
XFOR
X4 Pharmaceuticals
1/14/2025Reiterated Rating$16.96$45.00Buy
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
1/14/2025Reiterated Rating$12.79$22.00Buy
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
1/13/2025Reiterated Rating$14.68$33.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
1/13/2025Reiterated Rating$0.75$7.00Buy
MediWound Ltd. stock logo
MDWD
MediWound
1/10/2025Reiterated Rating$16.01$25.00Buy
My feud with Zohran Mamdani (Ad)

Nearly 40% of Americans now hold a positive view of socialism - and former hedge fund manager Whitney Tilson says what's unfolding in New York City is just the beginning. Tilson, a Harvard MBA who spent 30 years on Wall Street, has identified a specific economic pattern he believes points to a financial reset unlike anything seen in over 100 years. He's released a free analysis outlining what's coming and the exact steps he recommends you take with your money now.tc pixel

Read Whitney Tilson's free analysis and protect your wealth today
Absci Corporation stock logo
ABSI
Absci
1/8/2025Reiterated Rating$3.27$7.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
10/18/2024Boost Price Target$47.17$80.00Buy